U.S. Markets open in 42 hrs, 48 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 3.10 04:00 PM EDT | |
|---|---|---|
| Day High | 3.26 09:34 AM EDT |
|
| Range | 0.16 |
| Volume | 111,770 | |
|---|---|---|
| 30-Day Avg Vol | 102,000 |
|
| Difference | 9.58% |
| Market Cap | 121.85 M | |
|---|---|---|
| Mkt Cap Chg | -8.20 M |
| Shares Out | 39.05 M | |
|---|---|---|
| % Shrs Traded | 0.29% | |
| 1yr EPS Est | -1.37 |
| 52-Wk Low | 2.13 11/24/08 | |
|---|---|---|
| 52-Wk High | 6.05 9/8/08 |
|
| Range | 3.92 |
| Prev Close | 3.33 7/1/09 | |
|---|---|---|
| Today's Open | 3.25 | |
| Change | -2.40% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.94 M |
| Revenue (LFY) | 3.97 M | |
|---|---|---|
| Earnings (LFY) | -88.61 M | |
| Earnings (MRQ) | -19.66 M | |
| Next Earn Est | -0.40 | |
| Next Earnings | 08/03/2009 |
|
| EPS (TTM) | -2.27 | |
| 1yr EPS Growth | 39.65% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | -113.47 | |
| Beta | 0.66 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
For Neurocrine Biosciences, biology is all chemistry. The development-stage biotech develops treatments for neurological and endocrine-related diseases, such as insomnia, depression, and pain. Lead drug ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.4 8/3/09 | — — |
—
—
|
| Last Quarter | -0.389 3/31/09 | -0.51 3/31/09 |
-0.121
Missed
|
| 2 Quarters Ago | -0.496 12/31/08 | -0.75 12/31/08 |
-0.254
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 747,000.00 | 3.98 M |
| Gross Profit | -222,000.00 | -3.64 M |
| Operating Income | -14.30 M | -69.46 M |
| Net Income | -19.66 M | -88.61 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts